Moneycontrol PRO
Upcoming Event:Join us for New HorAIzon from Oct 6-7, 2pm and be a part of exciting conversations on tech & innovation
you are here: HomeNewsWorld

Fitch Group pledges $50,000 towards Give2Asia coronavirus relief fund

Give2Asia is an international non-profit organisation that coordinates funding between global donors with charitable projects and social enterprises across the Asia-Pacific region.

April 15, 2020 / 11:40 AM IST

Fitch Group has said it has pledged USD 50,000 to Give2Asia to fight coronavirus pandemic. Funds from Fitch and other donors will help towards the purchase of medical supplies, construction of hospitals, and providing frontline staff with food, lodging and subsidies.

Give2Asia is an international non-profit organisation that coordinates funding between global donors with charitable projects and social enterprises across the Asia-Pacific region.

It has launched a campaign to support frontline health workers and hospitals responding to the outbreak, including partnerships with several non-governmental organisations in China.

In a statement Fitch Group has said "it has donated USD 50,000 to Give2Asia in support of the organisation's crisis response to the outbreak of COVID-19".

Fitch Group Chief Executive Officer Paul Taylor said the company is deeply saddened by this tragedy. This donation is part of Fitch's ongoing efforts to complement other relief and recovery initiatives across the world.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Apr 15, 2020 11:35 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark